// App-Quantinova.ai

4466 : GULP1 is a potential tumor suppressor that modulates chemo-resistance through regulation of Nrf2-Keap1 signaling axis in urothelial carcinoma

Researchers

Presenter

  • Elisa Guida

Principal Investigators

  • Masamichi Hayashi

  • Alexander Baras

  • Leonel Maldonado

  • Mariana Brait

  • Leonardo Reis

  • akira oki

  • Evgeny Izumchenko

  • trinity bivalaqua

  • george J. Netto

  • Wayne Koch

  • David Sidransky

  • mohammad O. Hoque

Medical Centers

  • Johns Hopkins University, BALTIMORE, MD

  • University of South Alabama, Mobile, AL.

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Bladder Cancer

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved